At meeting held on 10 March 2022
The Board of Gland Pharma at its meeting held on 10 March 2022 has approved the appointment of Yao Fang (DIN: 09524705) as an Additional Director, categorized as Non Independent and Non-Executive Director, with effect from 10 March 2022. The Board also accepted the resignation of Li Dongming (DIN: 08047543) with effect from the conclusion of Board Meeting on 10 March 2022.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
